The rostral migratory stream plays a key role in intranasal delivery of drugs into the CNS

PLoS ONE

Volumn 6, Issue 4, 2011, Pages

  Scranton, Robert A ^a   Fletcher, Lauren ^a   Sprague, Shane ^a   Jimenez, David F ^a   Digicaylioglu, Murat ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITONIN; ERYTHROPOIETIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CENTRAL NERVOUS SYSTEM; CEREBELLUM; CONTROLLED STUDY; DRUG DISTRIBUTION; DRUG TRANSPORT; DRUG UPTAKE; HIPPOCAMPUS; LIQUID SCINTILLATION COUNTING; MALE; MOUSE; NONHUMAN; OLFACTORY BULB; ROSTRAL MIGRATORY STREAM; ANIMAL; BLOOD BRAIN BARRIER; C57BL MOUSE; INTRANASAL DRUG ADMINISTRATION; METABOLISM;

MUS;

ADMINISTRATION, INTRANASAL; ANIMALS; BLOOD-BRAIN BARRIER; CENTRAL NERVOUS SYSTEM; MALE; MICE; MICE, INBRED C57BL;

EID: 79954604168     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0018711     Document Type: Article

References (51)

1. Digicaylioglu M, (2010) Erythropoietin in stroke: quo vadis. Expert Opin Biol Ther 10: 937-949.
2. Rajapaksa TE, Bennett KM, Hamer M, Lytle C, Rodgers VG, et al. (2010) Intranasal M cell uptake of nanoparticles is independently influenced by targeting ligands and buffer ionic strength. J Biol Chem 285: 23739-23746.
3. Ehrenreich H, Weissenborn K, Prange H, Schneider D, Weimar C, et al. (2009) Recombinant human erythropoietin in the treatment of acute ischemic stroke. Stroke 40: e647-656.
4. Dhuria SV, Hanson LR, Frey WH 2nd, (2009) Intranasal delivery to the central nervous system: mechanisms and experimental considerations. J Pharm Sci 99: 1654-1673.
5. Alcala-Barraza SR, Lee MS, Hanson LR, McDonald AA, Frey WH 2nd, et al. (2010) Intranasal delivery of neurotrophic factors BDNF, CNTF, EPO, and NT-4 to the CNS. J Drug Target 18: 179-190.
6. Johnson NJ, Hanson LR, Frey WH, (2010) Trigeminal pathways deliver a low molecular weight drug from the nose to the brain and orofacial structures. Mol Pharm 7: 884-893.
7. Born J, Lange T, Kern W, McGregor GP, Bickel U, et al. (2002) Sniffing neuropeptides: a transnasal approach to the human brain. Nat Neurosci 5: 514-516.
8. Fehm HL, Smolnik R, Kern W, McGregor GP, Bickel U, et al. (2001) The melanocortin melanocyte-stimulating hormone/adrenocorticotropin(4-10) decreases body fat in humans. J Clin Endocrinol Metab 86: 1144-1148.
9. Reger MA, Craft S, (2006) Intranasal insulin administration: a method for dissociating central and peripheral effects of insulin. Drugs Today (Barc) 42: 729-739.
10. Reger MA, Watson GS, Green PS, Baker LD, Cholerton B, et al. (2008) Intranasal insulin administration dose-dependently modulates verbal memory and plasma amyloid-beta in memory-impaired older adults. J Alzheimers Dis 13: 323-331.
11. Danielyan L, Klein R, Hanson LR, Buadze M, Schwab M, et al. (2010) Protective effects of intranasal losartan in the APP/PS1 transgenic mouse model of Alzheimer disease. Rejuvenation Res 13: 195-201.
12. Merlin MA, Saybolt M, Kapitanyan R, Alter SM, Jeges J, et al. (2010) Intranasal naloxone delivery is an alternative to intravenous naloxone for opioid overdoses. Am J Emerg Med 28: 296-303.
13. Dhuria SV, Hanson LR, Frey WH 2nd, (2009) Intranasal delivery to the central nervous system: Mechanisms and experimental considerations. J Pharm Sci.
14. Fletcher L, Kohli S, Sprague SM, Scranton RA, Lipton SA, et al. (2009) Intranasal delivery of erythropoietin plus insulin-like growth factor-I for acute neuroprotection in stroke. Laboratory investigation. J Neurosurg 111: 164-170.
15. Lin S, Fan LW, Rhodes PG, Cai Z, (2009) Intranasal administration of IGF-1 attenuates hypoxic-ischemic brain injury in neonatal rats. Exp Neurol 217: 361-370.
16. Liu XF, Fawcett JR, Thorne RG, DeFor TA, Frey WH 2nd, (2001) Intranasal administration of insulin-like growth factor-I bypasses the blood-brain barrier and protects against focal cerebral ischemic damage. J Neurol Sci 187: 91-97.
17. Digicaylioglu M, Garden G, Timberlake S, Fletcher L, Lipton SA, (2004) Acute neuroprotective synergy of erythropoietin and insulin-like growth factor I. Proc Natl Acad Sci U S A 101: 9855-9860.
18. Guerra-Crespo M, Sistos A, Gleason D, Fallon JH, (2010) Intranasal administration of PEGylated transforming growth factor-alpha improves behavioral deficits in a chronic stroke model. J Stroke Cerebrovasc Dis 19: 3-9.
19. Kang YJ, Digicaylioglu M, Russo R, Kaul M, Achim CL, et al. (2010) Erythropoietin plus insulin-like growth factor-I protects against neuronal damage in a murine model of human immunodeficiency virus-associated neurocognitive disorders. Ann Neurol 68: 342-352.
20. Lois C, Alvarez-Buylla A, (1994) Long-distance neuronal migration in the adult mammalian brain. Science 264: 1145-1148.
21. Doetsch F, Alvarez-Buylla A, (1996) Network of tangential pathways for neuronal migration in adult mammalian brain. Proc Natl Acad Sci U S A 93: 14895-14900.
22. Altman J, (1962) Are new neurons formed in the brains of adult mammals? Science 135: 1127-1128.
23. Altman J, Das GD, (1965) Autoradiographic and histological evidence of postnatal hippocampal neurogenesis in rats. J Comp Neurol 124: 319-335.
24. Altman J, (1969) Autoradiographic and histological studies of postnatal neurogenesis. IV. Cell proliferation and migration in the anterior forebrain, with special reference to persisting neurogenesis in the olfactory bulb. J Comp Neurol 137: 433-457.
25. Luskin MB, (1993) Restricted proliferation and migration of postnatally generated neurons derived from the forebrain subventricular zone. Neuron 11: 173-189.
26. Whitman MC, Fan W, Rela L, Rodriguez-Gil DJ, Greer CA, (2009) Blood vessels form a migratory scaffold in the rostral migratory stream. J Comp Neurol 516: 94-104.
27. Nie K, Molnar Z, Szele FG, (2010) Proliferation but not migration is associated with blood vessels during development of the rostral migratory stream. Dev Neurosci 32: 163-172.
28. Sakane T, Akizuki M, Taki Y, Yamashita S, Sezaki H, et al. (1995) Direct drug transport from the rat nasal cavity to the cerebrospinal fluid: the relation to the molecular weight of drugs. J Pharm Pharmacol 47: 379-381.
29. Thorne RG, Emory CR, Ala TA, Frey WH 2nd, (1995) Quantitative analysis of the olfactory pathway for drug delivery to the brain. Brain Res 692: 278-282.
30. Danielyan L, Schafer R, von Ameln-Mayerhofer A, Buadze M, Geisler J, et al. (2009) Intranasal delivery of cells to the brain. Eur J Cell Biol 88: 315-324.
31. Danielyan L, Schafer R, von Ameln-Mayerhofer A, Bernhard F, Verleysdonk S, et al. (2011) Therapeutic efficacy of intranasally delivered mesenchymal stem cells in a rat model of Parkinson disease. Rejuvenation Res 14: 3-16.
32. Curtis MA, Kam M, Nannmark U, Anderson MF, Axell MZ, et al. (2007) Human neuroblasts migrate to the olfactory bulb via a lateral ventricular extension. Science 315: 1243-1249.
33. Guerrero-Cazares H, Gonzalez-Perez O, Soriano-Navarro M, Zamora-Berridi G, Garcia-Verdugo JM, et al. (2011) Cytoarchitecture of the lateral ganglionic eminence and rostral extension of the lateral ventricle in the human fetal brain. J Comp Neurol 519: 1165-1180.
34. Wu H, Hu K, Jiang X, (2008) From nose to brain: understanding transport capacity and transport rate of drugs. Expert Opin Drug Deliv 5: 1159-1168.
35. Fletcher L, Kohli S, Sprague SM, Scranton RA, Lipton SA, et al. (2009) Intranasal delivery of erythropoietin plus insulin-like growth factor-I for acute neuroprotection in stroke. J Neurosurg.
36. Zueger M, Urani A, Chourbaji S, Zacher C, Roche M, et al. (2005) Olfactory bulbectomy in mice induces alterations in exploratory behavior. Neurosci Lett 374: 142-146.
37. Leonard BE, Tuite M, (1981) Anatomical, physiological, and behavioral aspects of olfactory bulbectomy in the rat. Int Rev Neurobiol 22: 251-286.
38. Lennington JB, Yang Z, Conover JC, (2003) Neural stem cells and the regulation of adult neurogenesis. Reprod Biol Endocrinol 1: 99.
39. Illum L, (2004) Is nose-to-brain transport of drugs in man a reality? J Pharm Pharmacol 56: 3-17.
40. Hanson LR, Frey WH 2nd, (2008) Intranasal delivery bypasses the blood-brain barrier to target therapeutic agents to the central nervous system and treat neurodegenerative disease. BMC Neurosci 9 (Suppl 3): S5.
41. Sofroniew MV, Vinters HV, (2010) Astrocytes: biology and pathology. Acta Neuropathol 119: 7-35.
42. Janeczko K, (1989) Spatiotemporal patterns of the astroglial proliferation in rat brain injured at the postmitotic stage of postnatal development: a combined immunocytochemical and autoradiographic study. Brain Res 485: 236-243.
43. Mucke L, Oldstone MB, Morris JC, Nerenberg MI, (1991) Rapid activation of astrocyte-specific expression of GFAP-lacZ transgene by focal injury. New Biol 3: 465-474.
44. Norenberg MD, (1994) Astrocyte responses to CNS injury. J Neuropathol Exp Neurol 53: 213-220.
45. Alonso G, Prieto M, Chauvet N, (1999) Tangential migration of young neurons arising from the subventricular zone of adult rats is impaired by surgical lesions passing through their natural migratory pathway. J Comp Neurol 405: 508-528.
46. Prosser HM, Bradley A, Caldwell MA, (2007) Olfactory bulb hypoplasia in Prokr2 null mice stems from defective neuronal progenitor migration and differentiation. Eur J Neurosci 26: 3339-3344.
47. Chazal G, Durbec P, Jankovski A, Rougon G, Cremer H, (2000) Consequences of neural cell adhesion molecule deficiency on cell migration in the rostral migratory stream of the mouse. J Neurosci 20: 1446-1457.
48. Moraes L, de Moraes Mello LE, Shimabukuro MK, de Castro Batista CM, Mendez-Otero R, (2009) Lack of association between PSA-NCAM expression and migration in the rostral migratory stream of a Huntington's disease transgenic mouse model. Neuropathology 29: 140-147.
49. Kaneko N, Marin O, Koike M, Hirota Y, Uchiyama Y, et al. (2010) New neurons clear the path of astrocytic processes for their rapid migration in the adult brain. Neuron 67: 213-223.
50. Francis GJ, Martinez JA, Liu WQ, Xu K, Ayer A, et al. (2008) Intranasal insulin prevents cognitive decline, cerebral atrophy and white matter changes in murine type I diabetic encephalopathy. Brain 131: 3311-3334.
51. Martinez JA, Francis GJ, Liu WQ, Pradzinsky N, Fine J, et al. (2008) Intranasal delivery of insulin and a nitric oxide synthase inhibitor in an experimental model of amyotrophic lateral sclerosis. Neuroscience 157: 908-925.